Blank Cover Image

Efficacy of colestimide coadministered with atorvastatin in Japanese patients with heterozygous familial hypercholesterolemia (FH)

フォーマット:
論文
責任表示:
Kawashiri, Masaaki ; Higashikata, Toshinori ; Nohara, Atsushi ; Kobayashi, Junji ; Inazu, Akihiro ; Koizumi, Junji ; Mabuchi, Hiroshi
言語:
英語
出版情報:
日本循環器学会, 2005-05-01
著者名:
Kawashiri, Masaaki
Higashikata, Toshinori
Nohara, Atsushi
Kobayashi, Junji
Inazu, Akihiro
Koizumi, Junji
Mabuchi, Hiroshi
続きを見る
掲載情報:
Circulation Journal
ISSN:
1346-9843  CiNii Research  Webcat Plus  JAIRO
巻:
69
通号:
5
開始ページ:
515
終了ページ:
520
バージョン:
publisher
概要:
金沢大学大学院医学系研究科 <br />Background: Colestimide, a 2-methylimidazole-epichlorohydrin polymer, is a new bile-acid-sequestering resin, that is 4-fold as powerful at lowering low-density lipoprotein cholesterol (LDL-C) as the conventional re sin (cholestyramine). Moreover, colestimide has excellent patient compliance because it is available in tablet form. Methods and Results: The clinical efficacy of colestimide coadministered with atorvastatin on lipid and apolipoprotein concentrations was examined in 15 patients (M/F = 10/5, mean±SE age=54±9 years) with heterozygous familial hypercholesterolemia (FH). After a period of wash-out of any lipid-lowering drugs, atorvastatin (20-40mg) was administered to patients for at least 8 weeks, and then 3 g of colestimide was administered for a further 8 weeks. Total and LDL-C significantly (<0.0001) decreased by 35% from 361 to 233mg/dl and 41% from 274 to 161 mg/dl, respectively. Addition of colestimide caused a further significant 12% and 20% reduction, respectively, from the initial values to 205 and 129 mg/dl, respectively. Colestimide was also effective in reducing serum LDL-C concentrations in heterozygous FH patients with hypertriglyceridemia (triglycerides ≥150mg/dl). Conclusions: When monotherapy with atorvastatin is insufficient to treat severely hypercholesterolemic patients, such as those with heterozygous FH, colestimide acts to reinforce the action of statins. 続きを見る
URL:
http://hdl.handle.net/2297/7212
タイトル・著者・出版者が同じ資料

類似資料:

1
 
2
 
3
 
4
 
5
 
6
 
7
 
8
 
9
 
10
 
11
 
12
 

Nozue, Tsuyoshi, Kawashiri, Masa-aki, Higashikata, Toshinori, Nohara, Atsushi, Inazu, Akihiro, Kobayashi, Junji, &hellip;

Japan Atherosclerosis Society = 日本動脈硬化学会

Tada, Hayato, Kobayashi, Junji, Kawashiri, Masa-aki, Miyashita, Kazuya, Nohara, Atsushi, Inazu, Akihiro, Nakajima, &hellip;

BioMed Central

Yagi, Kunimasa, Hifumi, Senshu, Nohara, Atsushi, Higashikata, Toshinori, Inazu, Akihiro, Mizuno, Kiyoo, Namura, &hellip;

日本循環器学会

Tsuchida, Masayuki, Kawashiri, Masa-aki, Tada, Hayato, Takata, Mutsuko, Nohara, Atsushi, Ino, Hidekazu, Inazu, Akihiro, &hellip;

Japanese Circulation Society = 日本循環器学会

Tada, Hayato, Kawashiri, Masa-aki, Ohtani, Rumiko, Noguchi, Tohru, Nakanishi, Chiaki, Konno, Tetsuo, Hayashia, Kenshi, &hellip;

Elsevier Science Ireland

Nozue, Tsuyoshi, Higashikata, Toshinori, Inazu, Akihiro, Kawashiri, Masa-aki, Nohara, Atsushi, Kobayashi, Junji, &hellip;

Japanese Society of Internal Medicine = 日本内科学会

Tada, Hayato, Kawashiri, Masa-aki, Ohtani, Rumiko, Noguchi, Tohru, Nakanishi, Chiaki, Konno, Tetsuo, Hayashi, Kenshi, &hellip;

Elsevier

Mabuchi, Hiroshi, Nohara, Atsushi, Noguchi, Tohru, Kobayashi, Junji, Kawashiri, Masaaki, Tada, Hayato, Nakanishi, &hellip;

Elsevier

Tada, Hayato, Kawashiri, Masa-aki, Ohtani, Rumiko, Noguchi, Tohru, Nakanishi, Chiaki, Konno, Tetsuo, Hayashi, Kenshi, &hellip;

Elsevier

Tada, Hayato, Kawashiri, Masa-aki, Nohara, Atsushi, Inazu, Akihiro, Kobayashi, Junji, Mabuchi, Hiroshi, Yamagishi, &hellip;

Japan Atherosclerosis Society = 日本動脈硬化学会

Tada, Hayato, Kawashiri, Masaaki, Noguchi, Tohru, Mori, Mika, Tsuchida, Masayuki, Takata, Mutsuko, Nohara, Atsushi, &hellip;

Elsevier

Mabuchi, Hiroshi, Nohara, Atsushi, Higashikata, Toshinori, Ueda, Kosei, Bujo, H., Matsushima, Teruhiko, Ikeda, &hellip;

Japan Atherosclerosis Society = 日本動脈硬化学会